Patent details

EP3519049 Title: SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL23 SPECIFIC ANTIBODY

Basic Information

Publication number:
EP3519049
PCT Application Number:
US2017054217
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178574711
PCT Publication Number:
WO2018064436
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL23 SPECIFIC ANTIBODY
French Title of Invention:
PROCÉDÉ SÛR ET EFFICACE DE TRAITEMENT DU PSORIASIS AVEC UN ANTICORPS SPÉCIFIQUE CONTRE L'IL-23
German Title of Invention:
SICHERES UND EFFIZIENTES VERFAHREN ZUR BEHANDLUNG VON PSORIASIS MIT ANTI-IL23-SPEZIFISCHEM ANTIKÖRPER
SPC Number:

Dates

Filing date:
29/09/2017
Grant date:
03/12/2025
EP Publication Date:
07/08/2019
PCT Publication Date:
05/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/12/2025
EP B1 Publication Date:
03/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/11/2025
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
10/12/2025
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
RANDAZZO, Bruce
Address:
United States (US)

2

Name:
WASFI, Yasmine
Address:
United States (US)

Priority

1

Priority Number:
201662402403 P
Priority Date:
30/09/2016
Priority Country:
United States (US)

2

Priority Number:
201762532068 P
Priority Date:
13/07/2017
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/24; A61P 25/00; A61P 37/00;

Publication

European Patent Bulletin

1

Issue number:
202549
Publication date:
03/12/2025
Description:
Grant (B1)

2

Issue number:
202602
Publication date:
07/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
10/12/2025 Power Of Attorney 1
11/12/2025 Outgoing Correspondence 1